Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials

[1] Ramachandran P(2016)Antifibrotics in chronic liver disease: tractable targets and translational challenges Lancet Gastroenterol Hepatol 1 328-340

[2] Henderson NC(2012)Primovist, Eovist: what to expect? J Hepatol 57 421-429

[3] Van Beers BE(2011)Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver Eur J Radiol 80 e284-e288

[4] Pastor CM(2016)Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism Br J Radiol 89 20150666-229

[5] Hussain HK(2015)Pathology-MRI correlation of hepatocarcinogenesis: recent update J Pathol Translat Med 49 218-264

[6] Tamada T(2016)Dynamic contrast-enhanced MRI for oncology drug development J Magn Reso Imaging 44 251-622

[7] Ito K(2012)Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI Dig Dis (Basel, Switzerland) 30 617-1811

[8] Yoshida K(2014)Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-to PLoS One 9 e114756-296

[9] Kanki A(2017)Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis Eur Radiol 27 1804-704

[10] Higaki A(2010)Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol 8 e1000412-468

[1] Ramachandran P(2016)Antifibrotics in chronic liver disease: tractable targets and translational challenges Lancet Gastroenterol Hepatol 1 328-340

[2] Henderson NC(2012)Primovist, Eovist: what to expect? J Hepatol 57 421-429

[3] Van Beers BE(2011)Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver Eur J Radiol 80 e284-e288

[4] Pastor CM(2016)Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism Br J Radiol 89 20150666-229

[5] Hussain HK(2015)Pathology-MRI correlation of hepatocarcinogenesis: recent update J Pathol Translat Med 49 218-264

[6] Tamada T(2016)Dynamic contrast-enhanced MRI for oncology drug development J Magn Reso Imaging 44 251-622

[7] Ito K(2012)Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI Dig Dis (Basel, Switzerland) 30 617-1811

[8] Yoshida K(2014)Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-to PLoS One 9 e114756-296

[9] Kanki A(2017)Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis Eur Radiol 27 1804-704

[10] Higaki A(2010)Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol 8 e1000412-468